Generic placeholder image

Cardiovascular & Hematological Disorders-Drug Targets


ISSN (Print): 1871-529X
ISSN (Online): 2212-4063

Pharmacoproteomics in Cardiac Hypertrophy and Atherosclerosis

Author(s): Alberto Lazaro, Gloria Alvarez-Llamas, Julio Gallego-Delgado, Fernando de la Cuesta, Julio Osende, Ma Eugenia G. Barderas and Fernando Vivanco

Volume 9, Issue 2, 2009

Page: [141 - 148] Pages: 8

DOI: 10.2174/187152909788488672

Price: $65


Proteomics applications to study the molecular effects of drug administration (pharmacoproteomics) on left ventricular hypertrophy (LVH) and atherosclerosis are here reviewed. In most cases, an absence of complete normalization after treatment is revealed, in contrast to what is reported by classical approaches.

Keywords: Atherosclerosis, cardiac hypertrophy, proteomics, pharmacoproteomics

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy